XML 41 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Tables)
3 Months Ended
Sep. 30, 2016
Summary of Significant Accounting Policies [Abstract]  
Other Income [Table Text Block]
The following table summarizes the components of other (expense) income, net:
 
Three Months Ended September 30,
 
2016
 
2015
Gains on derivatives not designated as hedging instruments (1)
$
77


$
2,367

Currency-related (losses) gains, net (2)
(2,966
)

5,034

Other gains (3)
757


1,841

Total other (expense) income, net
$
(2,132
)
 
$
9,242


_____________________
(1) Includes both realized and unrealized (losses) gains on derivative forward currency contracts not designated as hedging instruments.
(2) We have significant non-functional currency intercompany financing relationships subject to currency exchange rate volatility and the net currency related (losses) gains for the three months ended September 30, 2016 and 2015 are primarily driven by this intercompany activity. Includes unrealized losses of $1,434 for the three months ended September 30, 2016 related to certain cross-currency swaps designated as cash flow hedges which offset unrealized gains on the remeasurement of certain intercompany loans. The cross-currency swap contracts designated as cash flow hedges did not have an impact during the prior comparative period.
(3) During the three months ended September 30, 2016 and 2015, we recognized gains related to insurance recoveries of $650 and $1,587, respectively
Schedule of Weighted Average Number of Shares [Table Text Block]
The following table sets forth the reconciliation of the weighted-average number of ordinary shares:
 
Three Months Ended September 30,
 
2016
 
2015
Weighted average shares outstanding, basic
31,570,824

 
32,528,583

Weighted average shares issuable upon exercise/vesting of outstanding share options/RSUs/RSAs/PSUs (1)

 
1,228,795

Shares used in computing diluted net (loss) income per share attributable to Cimpress N.V.
31,570,824

 
33,757,378

Weighted average anti-dilutive shares excluded from diluted net (loss) income per share attributable to Cimpress N.V.
1,524,854

 
79,976